We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Colorectal cancer
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This study is an investigation into the medical outcomes of patients with rectal cancer who underwent a surgical procedure called "Total Mesorectal Excision" (TME) with the assistance of robotic technology. Instead of studying patients in real-time, we're taking a look back in time to analyse data from multiple medical centers where this robotic surgical technique was used.
The primary goal of our research is to determine whether the use of robots in TME surgery has a positive impact on the long-term health and recovery of patients with rectal cancer. We aim to collect and analyse data, comparing the outcomes of patients who had robot-assisted TME surgery with those who underwent traditional procedures.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2025 Results article in https://pubmed.ncbi.nlm.nih.gov/40221865/ (added 14/04/2025)
You can take part if:
Current inclusion criteria as of 05/02/2025:
1. All patients who underwent a laparoscopic or robotic proctectomy since 2014;
2. Aged 18 years or above;
3. Rectal cancer tumour located within 15 cm from the anal verge or 20 cm from the anorectal juncti
You may not be able to take part if:
Current exclusion criteria as of 05/02/2025:
1. Patients that underwent robotic TME surgery as part of a more complex procedure, for example a peritonectomy, or a synchronous colonic or hepatic resection.2. Patients that underwent palliative resection3. Patients that underwent emergency resection
_____
Previous exclusion criteria:
1. Patients that underwent an APER or Hartmann’s procedure2. Patients that underwent robotic TME surgery as part of a more complex procedure, for example a peritonectomy, or a synchronous colonic or hepatic resection. 3. Patients that underwent palliative resection4. Patients that underwent emergency resection
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Rauand
Duhoky
+44 (0)2392286000 ext 3529
Rauand.Duhoky@porthosp.nhs.uk
The study is sponsored by Portsmouth Hospitals NHS Trust and funded by Intuitive Foundation.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 56922
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
